97070 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Albumins
Sub-classes:ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY
#2PREPARATION OF BIOLOGICALLY ACTIVE COMPLEXES
#3RECOMBINANT ENGINEERING BACTERIUM FOR IMPROVING YIELD OF RECOMBINANT HUMAN ALBUMIN
#4IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
#5Methods of Treating PD-L1 Expressing Cancer
#6COMPOSITIONS FOR TREATING ECTOPIC CALCIFICATION DISORDERS, AND METHODS USING SAME
#7ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME
#8ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF
#9CELL CULTURE MEDIA CONTAINING COMBINATIONS OF PROTEINS
#10COLLOIDALLY STABLE HEME-ALBUMIN COMPLEXES AND METHODS OF MAKING AND USING THEREOF
#11CURCUMIN-PEPTIDE CONJUGATES AND FORMULATIONS THEREOF
#12THERAPEUTIC USE OF P75NTR NEUROTROPHIN BINDING PROTEIN
#13ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
#14IMPROVED MEDIA FOR THE EXPRESSION OF RECOMBINANT VITAMIN K-DEPENDENT PROTEINS
#15CONJUGATION OF LIPOPHILIC ALBUMIN-BINDING MOIETY TO RNA FOR IMPROVED CARRIER-FREE IN VIVO PHARMACOKINETICS AND GENE SILENCING
#16Lactose And Human Milk Oligosaccharides (HMOS) Production In Cells
#17SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#18COMPLEMENT FACTOR I-RELATED COMPOSITIONS AND METHODS
#19CLINICAL ASSESSMENT OF M-PROTEIN RESPONSE IN MULTIPLE MYELOMA
#20FUSION PROTEIN BETWEEN SHORT FORM ROD-DERIVED CONE VIABILITY FACTOR AND A HYDROPHILIC PEPTIDE
#21DNASE1-LIKE 3 AND ITS USE IN THERAPY
#22ANIMAL FREE- ALPHA-LACTALBUMIN AND BETA-LACTOGLOBULIN FUSION MILK PROTEINS AND A PROCESS FOR PREPARING THE SAME
#23ALBUMIN BINDING DOMAIN FUSION PROTEINS
#24Compositions and Methods for Killing PD-1 Positive Cells
#25BINDING AGENTS
#26Polymer of Protein-Conjugated Polysaccharide, Preparation Method Therefor, Enzyme-Stabilizing Composition Comprising Same, and Method for Detecting Target Nucleic Acid Molecule by Using Same
#27PLANT CELL LINE FOR PRODUCING ALBUMIN AT HIGH EFFICIENCY AND USE THEREOF
#28ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY
#29AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM
#30COMPOSITIONS AND METHODS RELATED TO IMMUNOGLOBULIN PROTEASES AND FUSIONS THEREOF
#31SERUM ALBUMIN-BASED FUSION PROTEIN, AND NANO-ASSEMBLY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#32ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF
#33PROTEIN ISOLATE
#34CHEESE FOOD COMPOSITIONS
#35METHOD FOR PRODUCING BIRD PRODUCING HUMAN IMMUNOGLOBULIN FC AND TARGET PROTEIN
#36ULINASTATIN POLYPEPTIDES
#37VIRAL VECTOR ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES IN FELINES
#38METHOD FOR PREPARING A CONDITIONALLY ACTIVE ANTIBODY OR ANTIBODY FRAGMENT
#39COMPOSITIONS COMPRISING A CASEIN AND METHODS OF PRODUCING THE SAME
#40Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases
#41RECOMBINANT FACTOR VIII PROTEINS
#42ALBUMIN BINDING PEPTIDE CONJUGATES AND METHODS THEREOF
#43Method of using a genetically modified mouse that expresses human albumin
#44Compositions for treating ectopic calcification disorders, and methods using same
#45CLINICAL ASSESSMENT OF M-PROTEIN RESPONSE IN MULTIPLE MYELOMA
#46METHOD FOR POLISHING ALBUMIN
#47IL-10 AND USES THEREOF
#48IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
#49TARGETED PROTEIN CONTRAST AGENTS, METHODS OF MAKING, AND USES THEREOF
#50Protein-based films
#51Compositions and methods for increasing the efficiency of cell cultures used for food production
#52COMPOSITIONS AND METHODS FOR INCREASING THE EFFICIENCY OF CELL CULTURES USED FOR FOOD PRODUCTION
#53METHODS OF TREATING PD-L1 EXPRESSING CANCER
#54Cell culture media containing combinations of proteins
#55AAV-ZYME AND USE FOR INFUSION REPLACEMENT THERAPY
#56ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
#57Activatable fusion protein and use thereof
#58ULINASTATIN POLYPEPTIDES FOR TREATING DISEASES
#59Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing
#60COMPOSITION AND METHOD FOR CRYOPRESERVATION OF CELLS
#61REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
#62RECOMBINANT MILK PROTEINS AND COMPOSITIONS COMPRISING THE SAME
#63ALBUMIN BINDING ANTIBODIES AND USE THEREOF
#64Engineering of DNASE enzymes for manufacturing and therapy
#65Compositions comprising a casein and methods of producing the same
#66Albumin binding domain fusion proteins
#67Engineered human extracellular DNASE enzymes
#68Methods and reagents for modulating macrophage phenotype
#69Conditionally active polypeptides and methods of generating them
#70New Tools for Improving Gene Therapy and Use Thereof
#71PROTOXIN-II VARIANTS AND METHODS OF USE
#72MACROPINOCYTOSIS IN CANCER
#73Compositions and methods for increasing the efficiency of cell cultures used for food production
#74Albumin binding peptide conjugates and methods thereof
#75Method for producing active form of long-acting insulin analogue derivative using clostripain
#76METHODS OF USING DNASE1-LIKE 3 IN THERAPY
#77CULTURE MEDIUM FOR ASSISTED REPRODUCTIVE TECHNOLOGY
#78Ulinastatin polypeptides
#79Nucleic acid molecules encoding activin receptor type IIA variants
#80Regulatory T cell epitopes, compositions and uses thereof
#81Regulatory T cell epitopes, compositions and uses thereof
#82MILK PROTEIN PRODUCTION IN TRANSGENIC PLANTS
#83Cell culture media containing combinations of proteins
#84Engineering of DNASE enzymes for manufacturing and therapy
#85MODIFIED RNA WITH DECREASED IMMUNOSTIMULATORY PROPERTIES
#86Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
#87Amino acid sequences that modulate the interaction between cells of the immune system
#88Methods of treating PD-L1 expressing cancer
#89PREPARATION OF BIOLOGICALLY ACTIVE COMPLEXES
#90Therapeutic protein compositions and methods
#91Nucleic acids encoding p75NTR neurotrophin binding proteins
#92Targeted protein contrast agents, methods of making, and uses thereof
#93COMPOSITIONS COMPRISING A CASEIN AND METHODS OF PRODUCING THE SAME
#94COMPOSITIONS COMPRISING A CASEIN AND METHODS OF PRODUCING THE SAME
#95Compositions for Treating Ectopic Calcification Disorders, and Methods Using Same
#96Serpin fusion polypeptides and methods of use thereof
#97Factor IX polypeptides and methods of use thereof
#98FOOD COMPOSITIONS COMPRISING MILK PROTEINS PRODUCED IN TRANSGENIC PLANTS
#99Methods and Materials for Producing Hybrid Cell Lines
#100MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS
#101FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF
#102Serpin fusion polypeptides and methods of use thereof
#103IL-22BP COMPOSITIONS AND METHOD FOR THE TREATMENT OF DISEASE THEREWITH
#104Curcumin-peptide conjugates and formulations thereof
#105Targeted protein contrast agents, methods of making, and uses thereof
#106Protein isolate and process for the production thereof
#107Albumin variants and conjugates
#108Genetically modified mouse that expresses human albumin
#109Methods of using DNASE1-like 3 in therapy
#110Cell culture media containing combinations of proteins
#111METHOD FOR POLISHING ALBUMIN
#112Agents and methods for diagnosing fish allergy
#113Conditionally active polypeptides and methods of generating them
#114Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities
#115Human coagulation factor IX (FIX) fusion protein, preparation method therefor, and use thereof
#116PREPARATION OF BIOLOGICALLY ACTIVE COMPLEXES
#117Therapy using a factor XII inhibitor in a neurotraumatic disorder
#118MILK PROTEIN PRODUCTION IN TRANSGENIC PLANTS
#119Manufacturing and engineering of DNASE enzymes for therapy
#120SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#121Methods for treatment of nephrotic syndrome and related conditions
#122PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#123Binding agents
#124Recombinant factor VIII proteins
#125Method for producing Wnt protein and method for storing Wnt protein
#126Multivalent heteromultimer scaffold design and constructs
#127IMMUNE SYSTEM MODULATORS
#128Method for efficient purification of human serum albumin
#129REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
#130Activin receptor type IIA variants and methods of use thereof
#131Methods and reagents for modulating macrophage phenotype
#132EPITHELIAL TUMOR CELL CULTURES
#133Activin receptor type IIa variants and methods of use thereof
#134Amino acid sequences that modulate the interaction between cells of the immune system
#135Adsorbent material
#136Combination with albumin, in particular for treating a cartilage defect
#137Factor IX polypeptides and methods of use thereof
#138Factor IX polypeptides and methods of use thereof
#139Regulatory T cell epitopes, compositions and uses thereof
#140Regulatory T cell epitopes, compositions and uses thereof
#141Pharmaceutical Compositions
#142Soluble glycoprotein V for treating thrombotic diseases
#143Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
#144Measurement of glycoprotein
#145Measurement of glycoprotein
#146Multivalent heteromultimer scaffold design and constructs
#147Clinical assessment of M-protein response in multiple myeloma
#148Protein-surfactant-monomer/polymer blends and copolymers for protein-based plastics
#149IL-2 superagonists in combination with anti-PD-1 antibodies
#150Albumin binding peptide conjugates and methods thereof
#151Regulatory T cell epitopes, compositions and uses thereof
#152Regulatory T cell epitopes, compositions and uses thereof
#153Albumin binding domain fusion proteins
#154Mutated von Willebrand factor
#155Compositions for Treating Ectopic Calcification Disorders, and Methods Using Same
#156Pharmaceutical Compositions
#157Media for the expression of recombinant vitamin K-dependent proteins
#158Recombinant human C1 esterase inhibitor and uses thereof
#159Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
#160High purity alpha lactalbumin and methods of making
#161MILK PROTEIN PRODUCTION IN TRANSGENIC PLANTS
#162Regulatory T cell epitopes, compositions and uses thereof
#163Regulatory T cell epitopes, compositions and uses thereof
#164Regulatory T cell epitopes, compositions and uses thereof
#165Regulatory T cell epitopes, compositions and uses thereof
#166Regulatory T cell epitopes, compositions and uses thereof
#167Regulatory T cell epitopes, compositions and uses thereof
#168Regulatory T cell epitopes, compositions and uses thereof
#169SIZE-SELECTIVE HEMOCOMPATIBLE POLYMER SYSTEM
#170Targeted protein contrast agents, methods of making, and uses thereof
#171Compositions comprising a casein and methods of producing the same
#172IL-22BP COMPOSITIONS AND METHOD FOR THE TREATMENT OF DISEASE THEREWITH
#173Factor IX Polypeptides and Methods of Use Thereof
#174Factor IX polypeptides and methods of use thereof
#175Factor IX Polypeptides and Methods of Use Thereof
#176ALBUMIN FUSION PROTEINS
#177Serpin fusion polypeptides and methods of use thereof
#178Composition for treating hyperlipidemia comprising oxyntomodulin derivative
#179Therapeutic use of p75NTR neurotrophin binding protein
#180Method for inactivation/removal of coagulation factors by precipitation
#181Long-lived polynucleotide molecules
#182Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing
#183Pharmaceutical Composition
#184Recombinant Phe-free proteins for use in the treatment of phenylketonuria
#185Fusion Protein Comprising Leptin and Methods for Producing and Using the Same
#186Method for efficient purification of human serum albumin
#187Chromatography device and method for filtering a solute from a fluid
#188Chloroplast Expressing Colostrum or Milk Polypeptides
#189Protoxin-II variants and methods of use
#190METHOD FOR SEPARATING ALPHA-LACTALBUMIN AND BETA-LACTOGLOBULIN
#191MODIFIED PROTEIN MATERIALS, METHODS AND USES THEREOF
#192Immune system modulators
#193Compositions comprising a casein and methods of producing the same
#194Biofabrication techniques for the implementation of intrinsic tissue geometries to an in vitro collagen hydrogel
#195Phosphorylcholine group-containing compound and phosphorylcholine complex
#196PROCESS OF AFOD AND AFCC AND MANUFACTURING AND PURIFICATION PROCESSES OF PROTEINS
#197Multivalent heteromultimer scaffold design and constructs
#198Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing the same
#199THERAPY USING A FACTOR XII INHIBITOR IN A NEUROTRAUMATIC DISORDER
#200Factor VIII Fusion Protein
#201Colostrum/milk protein compositions
#202Administrable microparticles in vivo through medical conduit
#203Recombinant factor VIII proteins
#204Methods for treatment of nephrotic syndrome and related conditions
#205FUSION PROTEINS COMPRISING FACTOR IX FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOF
#206Factor IX polypeptides and methods of use thereof
#207Hypericin albumin nanoparticle-serum antibody complex and preperation method and application thereof
#208RECOMBINANT FACTOR VIII PROTEINS
#209Engineered albumin binding polypeptide
#210Immune system modulators
#211Amino acid sequences that modulate the interaction between cells of the immune system
#212Method to concentrate von willebrand factor or complexes thereof
#213Amino acid sequences that modulate the interaction between cells of the immune system
#214Factor IX polypeptides and methods of use thereof
#215Chloroplast expressing colostrum or milk polypeptides
#216PROTOXIN-II VARIANTS AND METHODS OF USE
#217Factor IX polypeptides and methods of use thereof
#218Modified RNA with decreased immunostimulatory properties
#219Multivalent heteromultimer scaffold design and constructs
#220METHODS AND COMPOSITIONS RELATED TO LARGE SCALE PRODUCTION OF PROTEINS
#221Fusion protein comprising albumin and retinol-binding protein
#222Composition for treating hyperlipidemia comprising oxyntomodulin derivative
#223METHOD FOR PREPARING LOW ANTIGENIC FOOD AND LOW ANTIGENIC FOOD PREPARED BY SAID METHOD
#224Methods for isolating antibodies that bind sclerostin
#225Factor IX polypeptides and methods of use thereof
#226LONG-LIVED POLYNUCLEOTIDE MOLECULES
#227PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#228Process for isolation of plasma or serum proteins
#229Regulatory T cell epitopes, compositions and uses thereof
#230METHODS FOR ISOLATING BLOOD PRODUCTS FROM AN INTER-ALPHA INHIBITOR PROTEIN-DEPLETED BLOOD PRODUCT MATERIAL
#231Biologically active complex and its preparation
#232Curcumin-peptide conjugates and formulations thereof
#233Spider silk fusion protein structures for binding to an organic target
#234Nucleotide sequence and a process thereof
#235COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE
#236Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing the same
#237Serpin fusion polypeptides and methods of use thereof
#238Process for the purification of recombinant albumin
#239Therapeutic use of p75NTR neurotrophin binding protein
#240Methods of treating cancer with low density lipoprotein-related protein 6 (LRP6)—half life extender constructs
#241METHOD FOR PRODUCING MILK PROTEIN NANOPARTICLES
#242MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE
#243Plasma protein fractionation by sequential polyacid precipitation
#244ALBUMIN FUSION PROTEINS
#245IL-2 derivative polypeptides
#246Albumin formulation and use
#247Long acting biologically active luteinizing hormone (LH) compound
#248Thixotropic α-lactalbumin hydrogels, method for preparing same and uses thereof
#249METHODS FOR ISOLATING BLOOD PRODUCTS FROM AN INTER-ALPHA INHIBITOR PROTEIN-DEPLETED BLOOD PRODUCT MATERIAL
#250Methods for treatment of nephrotic syndrome and related conditions
#251Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof
#252Caprylate viral deactivation
#253SEQUENCE OF 55 NEW FOUND PROTEINS AND THEIR APPLICATION
#254HYPOALLERGENIC MUTANT POLYPEPTIDES BASED ON FISH PARVALBUMIN
#255METHOD FOR IMMOBILIZING ALBUMIN ON A SELF-ASSEMBLED MONOLAYER
#256Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life
#257Multivalent heteromultimer scaffold design and constructs
#258Biologically active complex and its preparation
#259METHOD FOR POLISHING ALBUMIN
#260Treatment with factor ix-albumin fusion protein
#261Method for inactivation/removal of coagulation factors by precipitation
#262Treatment with factor VII-albumin fusion protein
#263Fusion protein comprising albumin and retinol-binding protein
#264Serpin fusion polypeptides and methods of purification thereof
#265Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
#266Albumin Fusion Proteins
#267PEGYLATED ALBUMIN POLYMERS AND USES THEREOF
#268Albumin Variants
#269Factor IX polypeptides and methods of use thereof
#270USE OF G-CSF DIMER IN THE TREATMENT OF NEUTROPENIA
#271AMINO ACID SEQUENCES OF NANOBODIES DIRECTED AGAINST P19 SUBUNIT OF THE HETERODIMERIC CYTOKINE IL-23
#272ALBUMIN FUSION PROTEINS
#273Factor VIII fusion protein
#274ALBUMIN FUSION PROTEINS
#275Serpin fusion polypeptides and methods of use thereof
#276Cell Culture Media Containing Combinations of Proteins
#277Interleukin-11 Fusion Proteins
#278ALBUMIN FUSION PROTEINS
#279Multivalent heteromultimer scaffold design and constructs
#280Albumin fusion proteins
#281Albumin Fusion Proteins
#282Disrupting FCRN-albumin interactions
#283LONG LASTING FUSION PEPTIDE INHIBITORS FOR HIV INFECTION
#284Complex and production process
#285METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES
#286Albumin variants and conjugates
#287PROCESS FOR THE PRODUCTION OF PREFORMED CONJUGATES OF ALBUMIN AND A THERAPEUTIC AGENT
#288Process for the purification of recombinant albumin
#289Albumin Fusion Proteins
#290Whey Protein Hydrolysate Containing Tryptophan Peptide Consisting of Alpha Lactalbumin and the Use Thereof
#291AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM
#292PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#293Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-life
#294REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
#295Conversion coating for aluminum and its alloys and articles thereof
#296Polynucleotide encoding a sclerostin-binding antibody
#297Recombinant albumins fused with poly-cysteine peptide and the methods for preparing the same
#298Hypoallergenic Mutant Polypeptides Based on Fish Parvalbumin
#299Albumin Fusion Proteins
#300Peptide standards